Seoul National University Hospital Obstetrics and Gynecology Kim Se-ik

Kim Se-ik

Seoul National University Hospital|Obstetrics and Gynecology

Seoul Jongno-gu

Last updated

Provides specialized care in gynecologic oncology, supported by clinical experience and academic activities.

Medical opinions · Patient reviews0

No reviews yet.

If you've been treated by Kim Se-ik, be the first to leave a review.

Planning to see Kim Se-ik?

Save this doctor and find them again anytime on My page.

Ask other patients

If reviews don't answer your questions, ask patients and caregivers who have been there.

Browse the community

Hospital information

Address
101 Daehak-ro, Jongno-gu, Seoul
University
서울대학교 의과대학
Appointments
1588-5700Book by phone (1588-5700)
All doctors at Seoul National University Hospital

Education and career

Education

  • 2014–2019 Seoul National University Graduate School (Doctor of Medicine)
  • 2012–2014 Seoul National University Graduate School (Master of Medicine)
  • 2005–2009 Seoul National University College of Medicine

Career

  • September 2025–Present Clinical Associate Professor, Department of Obstetrics and Gynecology, Seoul National University Hospital
  • July 2025 2025 Asian Society of Gynecologic Oncology Meeting – Journal of Gynecologic Oncology – Best Reviewer Award
  • April 2025 2025 Korean Society of Gynecologic Oncology International Conference – Travel Award
  • April 2025 2025 Korean Society of Gynecologic Oncology International Conference – Journal of Gynecologic Oncology – Best Reviewer Award
  • March 2025–August 2025 Clinical Associate Professor, Department of Obstetrics and Gynecology, Seoul National University Hospital
  • Title: Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy
  • Journal: J Gynecol Oncol. 2024 Mar 18. doi: 10.3802/jgo.2024.35.e73. Online ahead of print.
  • Publication date: 2024-03-29
  • PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/38551024/
  • Other URL: 10.3802/jgo.2024.35.e73
  • Title: The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023
  • Journal: J Gynecol Oncol. 2024 Mar;35(2):e67. doi: 10.3802/jgo.2024.35.e67. Epub 2024 Feb 27.
  • Publication date: 2024-03-08
  • PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/38456589/
  • Other URL: 10.3802/jgo.2024.35.e67
  • Title: Mitochondrial fission enhances IL-6-induced metastatic potential in ovarian cancer via ERK1/2 activation
  • Journal: Cancer Sci. 2024 Mar 3. doi: 10.1111/cas.16064. Online ahead of print.
  • Publication date: 2024-03-03
  • PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/38433313/
  • Other URL: 10.1111/cas.16064
  • Title: Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer
  • Journal: J Gynecol Oncol. 2024 Mar;35(2):e66. doi: 10.3802/jgo.2024.35.e66. Epub 2024 Jan 25.
  • Publication date: 2024-02-08
  • PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/38330382/
  • Other URL: 10.3802/jgo.2024.35.e66
  • Title: Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial
  • Journal: Gynecol Oncol. 2024 Mar;182:7-14. doi: 10.1016/j.ygyno.2023.12.029. Epub 2024 Jan 20.
  • Publication date: 2024-01-21
  • PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/38246047/
  • Other URL: 10.1016/j.ygyno.2023.12.029

Academic societies

  • December 2024–November 2026 Member, COI Subcommittee, Korean Society of Gynecologic Oncology
  • December 2024–November 2026 Member, Research Subcommittee, Korean Society of Gynecologic Oncology
  • December 2024–November 2026 Member, Hereditary Gynecologic Cancer Subcommittee, Korean Society of Gynecologic Oncology
  • December 2024–November 2026 Member, Editorial and Publication Subcommittee, Korean Society of Gynecologic Oncology
  • January 2024–December 2025 Chair, Innovation TFT, Korean Society of Gynecologic Robotic Surgery
  • January 2024–December 2025 Member, Public Relations Committee, Korean Gynecologic Cancer Translational Research Group
  • May 2023–Present Secretary, Planning and Operations Committee, Korean Association of Medical Journal Editors
  • February 2023–January 2024 Member, Annual Report on the Status of Cancer Research Publication Committee, Korean Cancer Association
  • December 2022–November 2024 Secretary, Newsletter Subcommittee, Korean Society of Gynecologic Oncology
  • December 2022–November 2024 Member, Research Subcommittee, Korean Society of Gynecologic Oncology
  • December 2022–November 2024 Member, Information and Communications Committee, Korean Society of Gynecologic Oncology
  • October 2022–November 2024 Member, Academic Committee, Korean Society of Gynecologic Oncology
  • March 2018–Present Associate Editor, Journal of Gynecologic Oncology
  • August 2017–Present Member, Ovarian Cancer Subcommittee, Korean Gynecologic Oncology Research Group

FAQ

What conditions does Kim Se-ik treat?
Kim Se-ik (Obstetrics and Gynecology, Seoul National University Hospital) treats conditions such as Gynecologic cancer (cervical cancer, endometrial cancer, uterine cancer, fallopian tube cancer, vulvar cancer, vaginal cancer).
Where does Kim Se-ik see patients?
In Obstetrics and Gynecology at Seoul National University Hospital. The hospital address is 101 Daehak-ro, Jongno-gu, Seoul.
What is Kim Se-ik's specialty?
Specialty: Obstetrics and Gynecology.

Is any information wrong?

Let us know about changes to hospital, specialty, career and so on, and we'll update it after checking.